Stephanie Greene

1.7k citations

18 papers · 1.3k indexed · 1 hit paper · h-index 9

Cancer Research top 5%
- Cancer Genomics and Diagnostics 11
Cell Biology top 5%
- Endoplasmic Reticulum Stress and Disease 2
Pulmonary and Respiratory Medicine top 5%
- Prostate Cancer Treatment and Research 3
- Lung Cancer Treatments and Mutations 3
Oncology top 10%
- Cancer Cells and Metastasis 7
- Cancer Immunotherapy and Biomarkers 2
Molecular Biology
- DNA Repair Mechanisms 3
Endocrine and Autonomic Systems
- Regulation of Appetite and Obesity 1

Co-authors: Ryan Dittamore Ryon P. Graf Dena Marrinucci David Lu Martin Fleisher Nicole A. Schreiber Brigit McLaughlin Howard I. Scher
Cited by: Cancer Research Cell Biology Pulmonary and Respiratory Medicine
Journals: Nature Communications (2 papers)Journal of Clinical Oncology (6 papers)SHILAP Revista de lepidopterología (1 paper)
Partner nations: United States Ireland Germany

In The Last Decade

Stephanie Greene

18 papers receiving 1.2k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Stephanie Greene

Since Specialization

Citations

This map shows the geographic impact of Stephanie Greene's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephanie Greene with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephanie Greene more than expected).

Fields of papers citing papers by Stephanie Greene

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephanie Greene. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephanie Greene. The network helps show where Stephanie Greene may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Stephanie Greene, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Stephanie Greene Line = papers co-authored together Stephanie Greene links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work
1	IRE1α-XBP1s pathway promotes prostate cancer by activating c-MYC signaling Nature Communications ·Xia Sheng,Hatice Zeynep Nenseth,Su Qu,Omer F. Kuzu,Turid Frahnow,Lukas M. Simon,Stephanie Greene,Qingping Zeng,Ladan Fazli,Paul S. Rennie,Ian G. Mills,Håvard E. Danielsen,Fabian J. Theis,John B. Patterson,Yang Jin,Fahri Saatcioglu	2019	178
2	Inhibition of IRE1 RNase activity modulates the tumor cell secretome and enhances response to chemotherapy Nature Communications ·Susan E. Logue,Eoghan P. McGrath,Patricia A. Cleary,Stephanie Greene,Katarzyna Mnich,Aitor Almanza,Éric Chevet,Róisín M. Dwyer,Anup Mammen Oommen,Patrick Legembre,Florence Godey,Emma C. Madden,Brian Leuzzi,Joanna Obacz,Qingping Zeng,John B. Patterson,Richard Jäger,Adrienne M. Gorman,Afshin Samali	2018	214
3	Cellular Expression of PD-L1 in the Peripheral Blood of Lung Cancer Patients is Associated with Worse Survival Cancer Epidemiology Biomarkers & Prevention ·Daniel J. Boffa,Ryon P. Graf,Michelle C. Salazar,Jessica R. Hoag,David Lu,Rachel Krupa,Jessica Louw,Lyndsey Dugan,Yipeng Wang,Mark Landers,Mahipal Suraneni,Stephanie Greene,Marisa Magaña,Samir Makani,Lyudmila Bazhenova,Ryan Dittamore,Jorge J. Nieva	2017	61
4	Phenotypic Heterogeneity of Circulating Tumor Cells Informs Clinical Decisions between AR Signaling Inhibitors and Taxanes in Metastatic Prostate Cancer Cancer Research ·Howard I. Scher,Ryon P. Graf,Nicole A. Schreiber,Brigit McLaughlin,Adam Jendrisak,Yipeng Wang,Jerry Lee,Stephanie Greene,Rachel Krupa,David Lu,Pascal Bamford,Jessica E. Louw,Lyndsey Dugan,Hebert Alberto Vargas,Martin Fleisher,Mark Landers,Glenn Heller,Ryan Dittamore	2017	94
5	Single cell phenogenomic subtyping of circulating tumor cells (CTCs) identify intercellular tumor heterogeneity (het) and multiple resistance mechansisms in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC). Journal of Clinical Oncology ·Howard I. Scher,Ryon P. Graf,Adam Jendrisak,Nicole A. Schreiber,Brigit McLaughlin,Stephanie Greene,Ángel Rodríguez,Martin Fleisher,Jerry Lee,James Kelvin,Yipeng Wang,Mark Landers,Ryan Dittamore	2017	1
6	The use of whole genome copy number variation (CNV) to measure genomic instability in mCRPC CTCs. Journal of Clinical Oncology ·Yipeng Wang,Stephanie Greene,Ángel Rodríguez,Jerry Lee,Mark Landers,Ryan Dittamore,Dena Marrinucci	2016	2
7	Chromosomal Instability Estimation Based on Next Generation Sequencing and Single Cell Genome Wide Copy Number Variation Analysis PLoS ONE ·Stephanie Greene,Angel E. Dago,Laura Leitz,Yipeng Wang,Jerry Lee,Shannon L. Werner,Steven Gendreau,Premal H. Patel,Shidong Jia,Liangxuan Zhang,Eric Tucker,Michael Malchiodi,Ryon P. Graf,Ryan Dittamore,Dena Marrinucci,Mark Landers	2016	37
8	AR-V7 and CTC heterogeneity biomarkers additively to predict patient (pt) outcomes with taxanes relative to approved AR targeted therapy. Journal of Clinical Oncology ·Howard I. Scher,Ryon P. Graf,Nicole A. Schreiber,Brigit McLaughlin,David Lu,Jessica Louw,Adam Jendrisak,Stephanie Greene,Ángel Rodríguez,Lyndsey Dugan,Martin Fleisher,Jerry Lee,Yipeng Wang,Mark Landers,Ryan Dittamore	2016	4
9	Single CTC characterization to identify phenotypic and genomic heterogeneity as a mechanism of resistance to AR signaling directed therapies (AR Tx) in mCRPC patients. Journal of Clinical Oncology ·Howard I. Scher,Ryon P. Graf,Jessica Louw,Adam Jendrisak,Ann Johnson,Stephanie Greene,Ángel Rodríguez,Nicole A. Schreiber,Brigit McLaughlin,Lyndsey Dugan,Martin Fleisher,Jerry Lee,Yipeng Wang,Dena Marrinucci,Mark Landers,Ryan Dittamore	2016	2
10	CTC phenotype classifier to identify mCRPC patients (pts) with high genomic instability CTCs and to predict failure of androgen ecreptor signaling (AR Tx) and taxane (T) systemic therapies. Journal of Clinical Oncology ·Howard I. Scher,Adam Jendrisak,Ryon P. Graf,Nicole A. Schreiber,Brigit McLaughlin,Stephanie Greene,Ángel Rodríguez,Jessica Louw,Lyndsey Dugan,Laura Leitz,Martin Fleisher,Jerry Lee,Yipeng Wang,Mark Landers,Ryan Dittamore	2016	2
11	Association of AR-V7 on Circulating Tumor Cells as a Treatment-Specific Biomarker With Outcomes and Survival in Castration-Resistant Prostate Cancerbreakdown → JAMA Oncology ·Howard I. Scher,David Lu,Nicole A. Schreiber,Jessica Louw,Ryon P. Graf,Hebert Alberto Vargas,Ann Johnson,Adam Jendrisak,Richard Bambury,Daniel C. Danila,Brigit McLaughlin,Justin Wahl,Stephanie Greene,Glenn Heller,Dena Marrinucci,Martin Fleisher,Ryan Dittamore	2016	461
12	A single cell genomic signature to detect homologous recombination deficiency (HRD) and PARP inhibitors sensitivity using patient's circulating tumor cells (CTCs). Journal of Clinical Oncology ·Gordon Vansant,Angel E. Dago,Jerry Lee,Stephanie Greene,Laura Lietz,Yipeng Wang,Mark Landers,Ryan Dittamore	2016	3
13	Analytical Validation and Capabilities of the Epic CTC Platform: Enrichment-Free Circulating Tumour Cell Detection and Characterization Shannon L. Werner,Ryon P. Graf,Mark Landers,David T. Valenta,Matthew Schroeder,Stephanie Greene,Natalee Bales,Ryan Dittamore,Dena Marrinucci	2015	8
14	Analytical Validation and Capabilities of the Epic CTC Platform: Enrichment-Free Circulating Tumour Cell Detection and Characterization SHILAP Revista de lepidopterología ·Shannon L. Werner,Ryon P. Graf,Mark Landers,David T. Valenta,Matthew Schroeder,Stephanie Greene,Natalee Bales,Ryan Dittamore,Dena Marrinucci	2015	100
15	Abstract 1584: Analytical and clinical validation of the Epic Circulating Tumor Cell (CTC) Platform: enrichment-free CTC detection and biomarker characterization Cancer Research ·Ryon P. Graf,David T. Valenta,Mark Landers,Bryan Taggart,Stephanie Greene,Shannon L. Werner,Ryan Dittamore,Dena Marrinucci	2015	2
16	BMP signaling in congenital heart disease: New developments and future directions Birth Defects Research Part A Clinical and Molecular Teratology ·Jun Wang,Stephanie Greene,James F. Martin	2011	53
17	Serum α2-macroglobulin and α1-inhibitor 3 concentrations are increased in hypoalbuminemia by post-transcriptional mechanisms Kidney International ·Frazier T. Stevenson,Stephanie Greene,George A. Kaysen	1998	26
18	Use of Glycated Hemoglobin to Assess Glycemic Control in Wistar Diabetic Fatty Rats and Zucker Fatty Rats Obesity Research ·Ann Albright,Patricia R. Johnson,Stephanie Greene,Judith S. Stern	1994	6

About Stephanie Greene

Stephanie Greene is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 18 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (11 papers), Cancer Cells and Metastasis (7 papers), DNA Repair Mechanisms (3 papers), Prostate Cancer Treatment and Research (3 papers), Lung Cancer Treatments and Mutations (3 papers), Endoplasmic Reticulum Stress and Disease (2 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Regulation of Appetite and Obesity (1 paper). The work is most often cited by research in Cancer Research (507 citations), Cell Biology (294 citations) and Pulmonary and Respiratory Medicine (563 citations). Stephanie Greene has collaborated with scholars based in United States, Ireland and Germany. Frequent co-authors include Ryan Dittamore, Ryon P. Graf, Dena Marrinucci, David Lu, Martin Fleisher, Nicole A. Schreiber, Brigit McLaughlin, Howard I. Scher, Adam Jendrisak and Hebert Alberto Vargas. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact